M&A: Page 9
-
Retrieved from Catheter Precision website on September 13, 2022
Catheter Precision agrees to reverse merger, securing cash to target cardiac electrophysiology market
By merging into Ra Medical Systems, Catheter Precision has access to public markets and a pool of cash needed to bring its product to market.
By Nick Paul Taylor • Sept. 13, 2022 -
Courtesy of Illumina
Illumina’s hold on Grail depends now on separate appeals in US, Europe
Even as it plans to appeal a European Commission decision and the FTC plans to appeal a U.S. ruling, Illumina say it’s preparing for ‘strategic alternatives’ to its acquisition of early cancer detection firm Grail.
By Elise Reuter • Updated Sept. 7, 2022 -
Retrieved from Olympus on August 30, 2022
Olympus to sell microscope unit for $3.1B as it bolsters focus on medical technology
Bain Capital has taken the other side of the deal, paying $3.1 billion for a business it said is “at the frontier of digital optical technology in life sciences and industrial end markets.”
By Nick Paul Taylor • Aug. 30, 2022 -
Retrieved from NJ Medical School Website on August 25, 2022
Labcorp adds to hospital lab buying streak with New Jersey acquisition
The purchase comes as hospitals work to trim costs and testing firms seek stable revenue streams as COVID-19 testing winds down.
By Peter Green , Rebecca Pifer • Aug. 25, 2022 -
Courtesy of Standard Bariatrics
Teleflex will buy Standard Bariatrics for $170M to gain Titan stapler
Standard’s investors could receive an additional $130 million if the unit reaches certain commercial milestones under Teleflex’s ownership.
By Elise Reuter • Aug. 22, 2022 -
Permission granted by Akili Interactive
Akili raises $163M in ‘blank-check’ merger, plans to commercialize digital treatment for ADHD
Akili’s share price fell as much as 55 percent on the Nasdaq by mid-morning Monday, its first day of trading after merging with a special purpose acquisition company.
By Elise Reuter • Aug. 22, 2022 -
Boston Scientific acquires biomaterials firm Obsidio to bolster embolization business
Obsidio’s Gel Emobolic Material technology was cleared by the FDA in July.
By Ricky Zipp • Aug. 15, 2022 -
Courtesy of https://www.mementor.de/
ResMed buys Mementor for prescription digital health app, continuing German expansion
ResMed will integrate the startup into its German operation as a separate business segment and use it as a platform for further digital health development.
By Nick Paul Taylor • Aug. 4, 2022 -
Illumina vows to fight EU efforts to block $8B Grail merger
Illumina acquired the liquid biopsy company in 2021, despite pending anti-competitiveness investigations on both sides of the Atlantic.
By Elise Reuter • Updated Aug. 2, 2022 -
Alex Wong via Getty Images
BD buys MedKeeper for $93M to continue expansion into pharmacy technology
The company sees MedKeeper’s software as a solution for pharmacies facing COVID-related labor shortages.
By Nick Paul Taylor • July 29, 2022 -
Don MacKinnon via Getty Images
3M to spin out its healthcare business
The decision comes amid spin-offs by several large medtech firms, including J&J and GE.
By Elise Reuter • July 26, 2022 -
seb_ra via Getty Images
AbbVie agrees to pay $60M for rights to acquire implantable glaucoma device
The biotech company said the deal is an opportunity to grow its eye-care business.
By Elise Reuter • July 20, 2022 -
Illumina fails to block EU antitrust review of $8B Grail merger
By siding with the European Commission, the General Court has cleared the EU to resume a review that could lead to it blocking the deal and fining Illumina.
By Nick Paul Taylor • July 18, 2022 -
Permission granted by CathWorks
Medtronic lands option to buy artery disease player CathWorks for up to $585M
CathWorks has the right to compel Medtronic to complete the acquisition if it chooses not to exercise its option.
By Nick Paul Taylor • July 13, 2022 -
Chip Somodevilla via Getty Images
Ex-Mazor executive charged by SEC with insider trading over Medtronic's $1.6B buyout
Doron Tavlin, who was Mazor’s vice president of business development, is accused by the agency of profiting from his inside knowledge of the pending takeover.
By Nick Paul Taylor • July 11, 2022 -
Maks_Lab via Getty Images
Medtech M&A falls 85% but activity could rebound in second half: report
PwC highlights a range of barriers that could stop acquisitions, including supply chain issues, scrutiny from the Federal Trade Commission and geopolitical concerns.
By Nick Paul Taylor • June 24, 2022 -
atiatiati via Getty Images
Bioventus agrees to staggered payment plan to close stalled $315M CartiHeal takeover
Rising interest rates quashed a plan for Bioventus to fund the takeover of the joint repair company with a bond offering. Now, the deal will get much more expensive, J.P. Morgan analysts said.
By Nick Paul Taylor • June 23, 2022 -
Boston Scientific inks $230M deal to buy majority stake in M.I.Tech
M.I.Tech is a South Korean manufacturer of endoscopic and urologic medical devices. Analysts at BTIG said the deal complements Boston Scientific’s non-vascular stent portfolio and boosts its international presence.
By Nick Paul Taylor • June 16, 2022 -
ResMed to acquire German health software company MediFox for $1B
The acquisition continues a pattern of medical device companies buying software platforms. ResMed expects the deal to close by the end of the year.
By Ricky Zipp • June 14, 2022 -
Oracle closes $28B buy of 'huge growth engine' Cerner
With the deal’s close, the days of standalone EHR vendors are increasingly in the rearview mirror.
By Rebecca Pifer • June 10, 2022 -
Permission granted by Becton Dickinson
BD to acquire Parata for $1.53B as part of strategy to boost margins
The deal is expected to help Becton Dickinson reach its goal of a 25% operating margin by the end of 2025. J.P. Morgan analysts said it would be the most meaningful tuck-in deal since BD acquired Bard in 2017.
By Elise Reuter • June 7, 2022 -
Courtesy of Boston Scientific
Boston Scientific would be 'good fit' for increasingly acquisitive J&J, analysts say
A limited portfolio overlap could make Boston Scientific a target should Johnson & Johnson's CEO seek a large medtech acquisition.
By Nick Paul Taylor • May 31, 2022 -
Sascha Schuermann via Getty Images
Baxter raises forecasts for Hillrom synergies, allaying concerns over $10.5B takeover
Company executives said the additional cost savings emerged as they took a closer look at Hillrom’s real estate footprint.
By Nick Paul Taylor • May 26, 2022 -
Carol Highsmith. (2005). "Apex Bldg." [Photo]. Retrieved from Wikimedia Commons.
Medtronic completes Intersect acquisition following FTC order
The Federal Trade Commission required Medtronic to divest a subsidiary of Intersect ENT to complete the deal. Medtronic announced the $1.1 billion acquisition last August.
By Nick Paul Taylor • Updated May 16, 2022 -
choness via Getty Images
Digital health funding dropped in Q1 to lowest level since 2020: CB Insights
The report is directionally in line with the findings of an earlier report from Rock Health, which described how the drying up of deals in February and March may be an early sign of a correction in digital health venture capital funding.
By Nick Paul Taylor • April 14, 2022
Previous
